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Abstract
Background: RNF122 is a recently discovered RING finger protein that is associated with HEK293T cell viability and is 
overexpressed in anaplastic thyroid cancer cells. RNF122 owns a RING finger domain in C terminus and transmembrane 
domain in N terminus. However, the biological mechanism underlying RNF122 action remains unknown.
Results: In this study, we characterized RNF122 both biochemically and intracellularly in order to gain an 
understanding of its biological role. RNF122 was identified as a new ubiquitin ligase that can ubiquitinate itself and 
undergoes degradation in a RING finger-dependent manner. From a yeast two-hybrid screen, we identified calcium-
modulating cyclophilin ligand (CAML) as an RNF122-interacting protein. To examine the interaction between CAML 
and RNF122, we performed co-immunoprecipitation and colocalization experiments using intact cells. What is more, 
we found that CAML is not a substrate of ubiquitin ligase RNF122, but that, instead, it stabilizes RNF122.
Conclusions: RNF122 can be characterized as a C3H2C3-type RING finger-containing E3 ubiquitin ligase localized to 
the ER. RNF122 promotes its own degradation in a RING finger-and proteasome-dependent manner. RNF122 interacts 
with CAML, and its E3 ubiquitin ligase activity was noted to be dependent on the RING finger domain.
Background
The ubiquitin-proteasome system is involved in protein
degradation and many biological processes such as tran-
scription, cell cycle progression, antigen processing, cel-
lular defense, signaling, and apoptosis [1,2]. In the
ubiquitin-proteasome pathway, a ubiquitin-activating
enzyme (E1) activates ubiquitin (Ub) by attaching it to a
substrate via a thiol-ester linkage and then transferring
the complex formed to the active-site cysteine of a ubiq-
uitin carrier protein (E2). Formation of isopeptide bonds
between the C terminus of Ub and the lysines on the sub-
strate is catalyzed by a ubiquitin ligase (E3), which binds
the substrate and catalyzes the transfer of Ub from a spe-
cific E2 to the substrate. The formation of a chain of Ub
molecules on the substrate generally targets it for degra-
dation by the 26 S proteasome [3]. Comparative genome
analysis has revealed the presence of a few genes encod-
ing E1, others encoding E2, and hundreds encoding E3
ligases [4].
RING finger proteins contain a RING finger domain,
which was first identified as being encoded by the Really
Interesting New Gene in the early 1990 s [5]. The RING
finger domain contains 8 metal-binding residues that
coordinate 2 zinc atoms in an interleaved pattern to facil-
itate correct folding, which is necessary for the biological
actions of these proteins. Many RING finger proteins
have been identified as ubiquitin ligases and are known to
play an important role in various physiological processes.
For example, MDM2, a representative RING finger pro-
tein, is a ubiquitin ligase of p53 [6]. Further, Cbl is known
to play an important role in the ligand-induced ubiquit-
ination of epidermal growth factor receptor (EGFR) via a
mechanism that involves interaction between the RING
finger domain and UbcH7 [7]. The tumor necrosis factor
(TNF) receptor associated factors (TRAFs) contain a
RING finger domain at the N-terminal region; TNFs play
an important role in both adaptive and innate immunity
[8]. However, there are still hundreds of RING finger pro-
teins whose functions have yet to be characterized.
A cell-based screening performed in our laboratory
revealed that the RNF122 gene is associated with cell via-
bility [9]. RNF122 is expressed in several normal tissues
and in tumor tissues and cell lines; RNF122 has been
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localized to the endoplasmic reticulum (ER) and the
Golgi apparatus [10]. Comparative genomic hybridiza-
tion (CGH) has revealed that RNF122 is overexpressed in
anaplastic thyroid cancer cells [11]. However, RNF122
expression is not invariably detected in mammalian and
Escherichia coli cells. The presence of the RING finger
domain in RNF122 implies that RNF122 may be involved
in the ubiquitylation pathway; however, to date, there has
been no study that has sought to biochemically character-
ize of RNF122. Moreover, the mechanism of apoptosis
induction mediated by RNF122 remains unclear. Given
the importance of the biological functions of the RING
finger proteins and the overexpression of RNF122 in ana-
plastic thyroid cancer cells, a functional characterization
of this gene is highly warranted. The present study pro-
vides evidence that RNF122 is a new uncharacterized
ubiquitin ligase. Further, we demonstrate that RNF122
interacts with CAML.
Results
Characterization of RNF122 expression in mammalian cells 
and E. coli
Yu found that epitope-tagged RNF122 was not success-
fully expressed in mammalian and bacterial cells [11]. In
the present study, we performed similar experiments and
obtained the same results. However, northern blotting,
RT-PCR, and subcellular localization studies have dem-
onstrated the existence of RNF122 [10]. Many RING fin-
ger proteins are ubiquitin ligases that ubiquitinate
themselves to facilitate their degradation by the ubiquitin
proteasome. We accordingly examined the expression of
RNF122 in HeLa and HEK293T cells after treatment with
one of the ubiquitin proteasome inhibitors, namely,
MG132. As illustrated in Figure 1A, RNF122 was
detected in the MG132-treated cells. This result demon-
strates that RNF122 is a substrate of the ubiquitin protea-
some system. To verify the importance of the RING
finger domain in the stability of RNF122, a mutant
RNF122 gene was constructed using PCR-based muta-
genesis and transfected into HEK293T cells. Subse-
quently, the total protein was extracted and analyzed by
western blotting. The mutant RNF122 was detected in
cells not treated with MG132; further, its expression was
not significantly affected by MG132 treatment (Figure
1B). These results suggest that the RING finger domain is
critical for the degradation of RNF122. Figure 1A and 1B
shows 2 bands of approximately 18 kD and 26 kD, indi-
cating that RNF122 may be glycosylated; this result is
consistent with the fact that the RNF122 sequence con-
tains some potential N-linked glycosylation sites (NxT/S).
Moreover, treatment of the cells with tunicamycin, which
inhibits N-linked glycosylation, caused a shift in the pro-
tein bands (Figure 1A). These results indicate that
RNF122 is an N-linked glycosylated protein containing a
RING finger that catalyses its own degradation in a pro-
teasome-dependent manner.
We constructed a full-length GST-RNF122 fusion pro-
tein, but we were unable to demonstrate successful
expression of this protein in bacteria (data not shown),
which is consistent with the results obtained by Yu [11].
The transmembrane sites, usually represented by a
hydrophobic sequence, are not expressed in E. coli.
Hence, we constructed two truncated mutants of GST-
RNF122, namely, GST-RNF122ΔTM and GST-
mutRNF122ΔTM, in which the transmembrane (TM)
domain was deleted. As illustrated in Figure 1C, the
expression of both GST-RNF122ΔTM and GST-
mutRNF122ΔTM was inducible. These proteins were
purified successfully by affinity chromatography and con-
firmed by western blotting using an anti-GST antibody.
In vivo and in vitro ubiquitination of RNF122
To further examine the ubiquitination of RNF122, we
performed in vivo ubiquitination studies. We coex-
pressed RNF122-myc with HA-ubiquitin in HEK293T
cells, recovered the immunoprecipitates using anti-myc
antibody, and performed immunoblotting using the anti-
HA antibody. As shown in Figure 2A, a smeared band,
which indicates ubiquitination, appeared in the blots of
lysates of cells cotransfected with RNF122-myc and HA-
ubiquitin, but this was not detected in the vector control
group. Hence, we confirmed that RNF122 undergoes
ubiquitination in vivo. Further, we performed the same
experiment using an RNF122 mutated in the RING finger
domain and found that this mutant (RNF122C92A-myc)
was also ubiquitylated in vivo, as evident from the high-
molecular-weight smeared band detected on blots of the
lysates of the cells coexpressing RNF122C92A-myc and
ubiquitin (Figure 2A). However, the degree of ubiquitina-
tion of this mutant protein was significantly lower than
that of RNF122-myc; a finding that is consistent with the
proteasome degradation of the wild-type and mutant
RNF122.
The presence of the RING finger domain in RNF122
confers the properties of a ubiquitin ligase to this protein.
To investigate whether RNF122 has ubiquitin ligase activ-
ity, we established an in vitro autoubiquitination assay,
which was performed according to the manufacturer's
instructions. Briefly, E1, E2, and bacterially expressed
GST-RNF122ΔTM were added to a reaction mixture
containing ubiquitin and ATP. We treated the RNF122
fusion proteins with different E2 enzymes to determine
which E2 supports RNF122-mediated ubiquitination. As
is evident from Figure 2B, polyubiquitination was
detected only in cells treated with the following E2-conju-
gating enzymes: UbcH5a, UbcH5b, UbcH5c, Ubc6, and
Ubc13. To clarify the role of the RING finger domain in
ubiquitination, we performed an auto ubiquitinationPeng et al. BMC Cell Biology 2010, 11:41
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assay using RNF122 containing a single-site mutations
( C y s 9 2 A l a )  i n  t h e  R I N G  f i n g e r  d o m a i n  ( G S T -
RNF122C92A-ΔTM). As shown in Figure 2C, the muta-
tion compromised the autoubiquitylation activity of
UbcH5a, UbcH5b, UbcH5c, Ubc6, and Ubc13. These
results demonstrate that RNF122 is an E3 ligase that is
selective for UbcH5a, UbcH5b, UbcH5c, Ubc6, and
Ubc13.
RNF122 interacts with CAML
Next, the yeast two-hybrid system was used to identify
the potential substrates of RNF122. The experiments
were performed by Ruixing Corp. (Shanghai, China). The
results revealed that RNF122 interacts with CAML, a
protein associated with calcium signaling and T cell acti-
vation. To confirm the interaction between RNF122 and
CAML, we co-expressed these proteins in HEK293T cells
and immunoprecipitated RNF122-myc with the anti-myc
antibody. Western blot analysis of the immunoprecipitate
obtained using the anti-FLAG antibody revealed that
RNF122 but not its mutant form was coprecipitated with
FLAG-tagged CAML (CAML-FLAG), demonstrating
their association in mammalian cells (Figure 3A). The
results also suggested that CAML interacts with RNF122
through the RING finger domain. Hence, the RING fin-
ger protein functions as a ubiquitin ligase that ubiquitiny-
lates the substrate and targets it to the ubiquitin
proteasome system. We accordingly performed experi-
ments to determine whether CAML is a substrate of
RNF122 and whether it can be degraded by the ubiquitin
proteasome system. As shown in Figure 3B, however,
CAML levels in MG132-treated cells were not elevated,
suggesting that CAML may not be involved in the protea-
some-dependent degradation pathway. Furthermore,
CAML protein levels remained unchanged even when
CAML-FLAG and RNF122-myc or mutant RNF122 were
coexpressed (Figure 3C). Overall, we conclude that
CAML interacts with RNF122 but is not a substrate for
its ubiquitylating activity. Interestingly, RNF122 expres-
sion was occasionally detected in cells that overexpressed
CAML. As illustrated in Figure 3D, RNF122 was stabi-
lized when CAML was overexpressed. Hence, it can be
speculated that the interaction between CAML and
RNF122 inhibits the ubiquitination of RNF122, and
thereby stabilizes RNF122.
Figure 1 Characterization of RNF122 expression in mammalian and E. coli cells. (A). HEK293T and HeLa cells were transiently transfected with 
RNF122-myc. At 24 h post-transfection, the cells were treated with 2.5 μg/mL MG132 or 50 μg/mL tunicamycin and harvested at the indicated time. 
The cell lysates were subjected to SDS-PAGE and analyzed by western blotting using anti-myc and anti-β-actin antibodies. (B). HEK293T cells were 
transiently transfected with RNF122-myc or with RNF122C92A-myc or RNF122C95A-myc mutants. At 24 h post-transfection, the cells were treated 
with 50 μg/mL MG132, harvested after 6 h, and then analyzed by western blotting. (C). GST-RNF122ΔTM or GST-RNF122-ΔTM mutant proteins were 
expressed in E. coli and purified by affinity chromatography. The proteins were verified by SDS-PAGE and western blotting using an anti-GST primary 
antibody. a: pre-induction; b: post-induction; c: effluent obtained after affinity chromatography; d: purified protein.Peng et al. BMC Cell Biology 2010, 11:41
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Colocalization of RNF122 and CAML in HEK293T and HeLa 
cells
In order to confirm the intracellular interaction between
RNF122 and CAML, we constructed a plasmid, namely,
pEGFP-N1-RNF122, encoding green fluorescent protein,
and a CAML-FLAG-encoding plasmid and cotransfected
these into HeLa cells or HEK293T cells. As shown in Fig-
ure 4A, both pEGFP-N1-RNF122 and CAML-FLAG were
observed to be localized in the cytoplasm and were highly
concentrated in spots around the nucleus; moreover, the
distribution of CAML was similar to that of RNF122. Fur-
ther experiments on the localization of CAML yielded
the same result, namely, that CAML is partially localized
to the ER. This observation is consistent with our previ-
Figure 2 In vivo and in vitro ubiquitylation of RNF122. (A) HEK293T cells were seeded into 60-mm plates and transfected with 5 μg of Ub-HA and 
5 μg of pcDB (empty) or wild-type or mutant RNF122-myc expression plasmid. At 48 h post-transfection, cell lysates in RIPA buffer were immunopre-
cipitated with anti-myc antibody agarose beads. The immunoprecipitates were analyzed on an immunoblot for HA. A smeared band was observed 
in the RNF122-myc group. (B) E2-selective ubiquitin ligase activity of RNF122. Bacterially expressed GST-RNF122ΔTM was incubated with ubiquitin, E1, 
and various E2 enzymes. Autoubiquitylation of RNF122 was detected by HRP-streptavidin immunoblotting. (C) RNF122 E3 ligase activity required an 
intact RING finger domain. The reactions were performed using ubiquitin, E1, E2 (UbcH5b or UbcH5c), and E3 (GST-RNF122ΔTM, or mutant GST-
RNF122ΔTM), as indicated.Peng et al. BMC Cell Biology 2010, 11:41
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ous finding that RNF122 is localized to the ER. These
data confirmed that RNF122 and CAML interact to form
a complex that is functional in the cytoplasm.
The TM domain is critical to the localization of RNF122
RNF122 contains a putative TM domain near the N ter-
minus (amino acid residues 37-59). To investigate
whether this domain is required for the localization of
RNF122 to the ER, we generated a truncated mutant of
RNF122 in which 60 N-terminal amino acids were
deleted. The expression vectors pcDB/RNF122-ΔTM and
RNF122-ΔTM-GFP were constructed and used to evalu-
ate the functions and subcellular localization of the trun-
cated RNF122. The cytoplasmic expression pattern of the
RNF122 mutant was noted to be diffuse as compared to
the expression pattern of the wild-type RNF122 (Figure
4B), indicating that the N-terminal TM domain of
RNF122 is required for its specific localization. These
findings suggest that the putative N-terminal TM domain
is necessary for the localization of RNF122.
Discussion
The importance of the RING finger domain in ubiquit-
ination is supported by the fact that several RING finger
proteins are associated with Ubcs and/or specific pro-
teins destined for proteasome-dependent degradation,
although there have been no reports confirming their E3
activities toward these proteins.
In our previous study, we performed northern blotting
and RT-PCR analysis, and confirmed that RNF122 is
widely expressed in several tissues and cell lines and that
it is localized to the ER and the Golgi apparatus. A cell-
based screening test revealed that RNF122 can downreg-
ulate the expression of the prolactin (PRL) gene. Further
studies showed that RNF122 was associated with the via-
bility of HEK293T cells. However, the exact biological
function of RNF122 is still unknown. In the present study,
we characterized the biological role of RNF122. RNF122
contains a RING domain, which suggests that it catalyzes
its own degradation. Furthermore, through in vivo and in
vitro ubiquitination assays, RNF122 was identified as a
new ubiquitin ligase. We also found that the TM domain
of RNF122 is critical for its localization to the ER.
CAML is a ubiquitous protein containing 296 amino
acids. It contains 3 putative TM domains near its C ter-
minus and has been shown to be a resident protein of the
ER [12,13]. There are several proteins that can interact
with CAML, including CAML interactor (TACI) [14],
epidermal growth factor receptor (EGFR) [15], p56lck [16],
Kaposi's sarcoma virus-associated mitochondrial K7 pro-
Figure 3 Interaction of RNF122 with CAML. (A) In mammalian cells, RNF122 interacted with CAML. HEK293T cells were seeded into 60-mm plates 
and transfected with pcDB (empty), RNF122-myc or mut-RNF122-myc vectors in conjunction with CAML-FLAG. After 48 h, the cells were treated with 
2.5 μg/mL MG132 for 6 h, lysed in PBS containing 1% Triton X-100, and immunoprecipitated with anti-myc antibody agarose beads. (B) CAML is not 
involved in the proteasome-dependent degradation pathway. HEK293T cells were treated with 2.5 μM MG132 or vehicle (DMSO) for 6 h. The cells 
were then harvested and the expression of CAML was analyzed by western blotting using an anti-CAML antibody. The membrane was subsequently 
reprobed with an anti-β-actin antibody. (C) HEK293T cells were transiently cotransfected with CAML-FLAG and pcDB, RNF122-myc, RNF122C92A-myc, 
or RNF122C95A-myc. At 24 h post-transfection, the cells were treated with 50 μg/mL CHX and harvested at the indicated times. The cell lysates were 
subjected to SDS-PAGE and analyzed by western blotting by using antisera against FLAG and β-actin. (D) The level of RNF122 was found to increase 
in a proteasome-independent manner when it was coexpressed with CAML. HEK293T cells were transfected with empty (pcDB) or CAML expression 
vector along with RNF122-myc, and subsequently treated with 2.5 μg/mL MG132 or DMSO at 24 h post-transfection. After 24 h, the cell lysates were 
suspended in PBS containing 1% Triton X-100 and a protease inhibitor cocktail, and then immunoblotted with an anti-myc antibody.Peng et al. BMC Cell Biology 2010, 11:41
http://www.biomedcentral.com/1471-2121/11/41
Page 6 of 9
tein [17], type-1 angiotensin II receptor-associated pro-
tein (ATRAP) [18], and γ2 subunit-containing gamma-
aminobutyric acid type A receptor (GABAAR) [19]. Con-
sistent with the findings of the previous studies on
CAML, our findings showed that RNF122 interacts with
CAML. The coimmunoprecipitation and colocalization
experiments verified the interaction between RNF122
and CAML in mammalian cells and, at the same time,
showed that overexpression of RNF122 does not reduce
the CAML levels. Nonetheless, it seems unlikely that
CAML is a substrate for the ubiquitin ligase activity of
RNF122. This supposition is based on the observation
that CAML levels were not reduced by the coexpression
of RNF122 and were not increased in MG132-treated
cells.
We have validated the interaction between CAML and
RNF122 in vivo when the proteins are overexpressed,
which may not necessarily represent the endogenous
Figure 4 Subcellular localization of RNF122. (A) HeLa or HEK293T cells were grown on coverslips and transfected with RNF122-N1 and CAML-FLAG. 
To inhibit the degradation of RNF122-N1, the cells were treated with 2.5 μM MG132 for 6 h. The cells were then treated with anti-FLAG antibody and 
FITC-conjugated goat anti-mouse antibody, and observed under a confocal microscopy. The results showed that the cytoplasmic distribution of 
CAML entirely overlapped that of RNF122. (B) HEK293T cells were transfected with RNF122-N1 and RNF122ΔTM-N1 and observed under a fluores-
cence microscope.Peng et al. BMC Cell Biology 2010, 11:41
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condition. However, we have failed to testify endogenous
interaction because of the limited RNF122 expression
and its poor antibody. In the stability study, RNF122 can
be stabilized when CAML was overexpressed, which give
a clue that RNF122 and CAML are functional related. It
has been concluded that CAML has been proposed to
regulate trafficking of EGFR and the GABAA receptor.
The stalibility of EGFR and GABAA receptor can be mod-
ulated through c-Cbl and Plic-1 respectively, and they
both are involved in ubiquitin-proteasome system
[20,21]. So we speculate that RNF122 may regulate EGFR
and GABAA receptor stability through ubiquitin-protea-
some system. We are still focus on the biological role of
RNF122 in the next investigation. The results may give us
a new direction to clarify the biological function of
RNF122.
Previous study show that CAML can interact with
EGFR in ligand-dependent way, which gave us a clue that
RNF122 may involved in EGFR pathway. We have also
found that RNF122 effect on cell viability may relate to
ERK pathway (data not shown). However, the precise
molecular mechanisms such as the interaction between
EGFR and RNF122 still need to be further explored.
Conclusions
In conclusion, RNF122 can be characterized as a
C3H2C3-type RING finger-containing E3 ubiquitin ligase
localized to the ER. RNF122 promotes its own degrada-
tion in RING finger-and proteasome-dependent manner.
RNF122 interacts with CAML, and its E3 ubiquitin ligase
activity was noted to be dependent on the RING finger
domain. Further studies are required to clarify the molec-
ular mechanism, such as substrate binding, that underlie
RNF122 action.
Methods
Constructs and transfection
Full-length cDNA of RNF122  (GenBank accession no.
NM_024787.2) was obtained and pEGFP-N1-RNF122
was constructed according to previously described meth-
ods [10](Wang, Shi et al. 2006). RNF122-myc was ampli-
fied and then ligated into pcDNA.3.1/myc-His(-)B
(Invitrogen, USA). The first or the second cysteine resi-
due of the RING finger was substituted with an alanine
residue by polymerase chain reaction (PCR)-based site-
directed mutagenesis, which resulted in the formation of
products designated as RNF122C92A-myc or
RNF122C95A-myc, respectively. We get RNF122-ΔTM-
GFP and CAML-FLAG by inserting RNF122-ΔTM and
CAML into the pEGFP-N1 and pFLAG-CMV2 vectors
(Clontech, USA), respectively, using a PCR-based
method. The bacterially expressed GST-RNF122ΔTM or
GST-mutRNF122ΔTM fusion proteins (GST; glutathione
S-transferase) were obtained using PCR fragments
encoding residues 61-155 of human RNF122 or RNF122-
C92A-myc. The PCR primers contained XhoI and BamHI
sites. The resulting PCR fragment was inserted into the
pGEX-4T-1 vector (GE Healthcare, USA). All the inser-
tions were confirmed by DNA sequencing.
DNA transfection was performed using VigoFect (Vig-
orous, China), a non-liposomal cationic formula, accord-
ing to the manufacturer's instructions.
Prokaryotic expression
E. coli strain BL-21(DE3) (Novagen, Madison, WI) were
cultured overnight at 37°C and induced with 0.4 mM iso-
propyl-1-thio-β-D-galactopyranoside for 1 h at room
temperature (RT). The bacterial pellets were resuspended
in a solution containing 50 mM Tris (pH 7.4), 1 mM eth-
ylenediaminetetraacetic acid (EDTA), 1% Triton X-100, 5
mM dithiothreitol (DTT), and 2 mM phenylmethylsulfo-
nyl fluoride (PMSF) (sonication buffer), and lysed by
probe sonication using 4 mL of sonication buffer per 100
mL of bacterial culture. The sonicate was clarified by cen-
trifugation at 4°C for 15 min at 18,000 × g, divided into
aliquots, and stored at -70°C. To estimate the level of GST
fusion proteins expressed, the sonicates were incubated
with glutathione-Sepharose (GS) beads, washed, and sub-
jected to sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis (SDS-PAGE); subsequently, the gel was
stained with Coomassie Brilliant Blue R-250.
Cell lines and reagents
Human embryonic kidney cell line HEK293T and human
cervix carcinoma cell line HeLa were obtained from the
American Type Culture Collection (Manassas, VA).
HEK293T and HeLa cells were cultured (37°C, 5% CO2
humidified atmosphere) in Dulbecco's modified Eagle's
medium (DMEM) (Invitrogen, Carlsbad, CA) containing
10% fetal bovine serum (FBS) (Hyclone, Logan, UT) and
supplemented with 2 mM L-glutamine (Invitrogen, Carls-
bad, CA). Monoclonal mouse antibodies against β-actin,
c-myc, and FLAG were purchased from Sigma (Sigma-
Aldrich, St Louis, MO); horseradish peroxidase (HRP)-
streptavidin and HRP-myc antibodies, from Upstate
(USA); MG132, from Sigma (Sigma-Aldrich, St Louis,
MO); tunicamycin, from Alexis (USA); cycloheximide,
from Calbiochem (USA); and a ubiquitin-conjugating
enzyme kit (mammalian) from Biomol (USA).
Immunoprecipitation and immunoblotting
HEK293T cells were transiently transfected with the
epitope-tagged constructs using VigoFect, as described
above. Forty-eight hours after transfection, the cells were
washed 3 times in phosphate-buffered saline (PBS), har-
vested by scraping, and centrifuged (5 min, 500 × g). The
pelleted cells were homogenized in a cell lysis buffer [50Peng et al. BMC Cell Biology 2010, 11:41
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mmol/L Tris-HCl (pH 7.4), 150 mmol/L NaCl, 5 mmol/L
EDTA-Na2, 1% NP-40; 1 μg/μL pepstain, 1 μg/μL aproti-
nin, 1 μg/μL leupeptin, 1 mmol/L DTT, and 0.0174 μg/μL
PMSF]. The cell lysates thus obtained were centrifuged
(20 min, 14,000 × g, 4°C), and the resulting supernatants
were combined with 12.5 μL (packed gel) of either anti-c-
Myc or anti-FLAG M2 affinity agarose (Sigma-Aldrich, St
Louis, MO), mixed, and incubated in 4°C overnight. The
immunoadsorbents were recovered by centrifugation (5
min, 700 × g) and washed 3 times with a high-salt buffer
[500 mmol/L Tris-HCl (pH 7.4), 150 mmol/L NaCl, 5
mmol/L EDTA-Na2, 1% NP-40, 1 μg/μL pepstain, 1 μg/μL
aprotinin, 1 μg/μL leupeptin, 1 mmol/L DTT, and 0.0174
μg/μL PMSF], followed by re-suspension in cell lysis cen-
trifugation (5 min, 700 × g), and the same procedure was
repeated using PBS. The samples were then eluted using
60 μL of 2 × SDS loading buffer (Sigma-Aldrich, St Louis,
MO) and analyzed by western blotting using anti-myc or
anti-FLAG antibodies. Subsequently, the bands were
detected using Ig-HRP-conjugated antibodies and an
enhanced chemiluminescence (ECL) detection system
(GE Healthcare, USA).
Confocal microscopy
The HEK293T or HeLa cells were cotransfected with
pEGFP-N1-RNF122 and CAML22-N1 CCAML-FLAG,
grown on coverslips, fixed using 3.7% paraformaldehyde
at RT for 30 min, and then permeabilized with 0.1% Tri-
ton X-100 at RT for a further 10 min. The cover slips were
washed 3 times with PBS, treated with a blocking buffer
(5% bovine serum albumin in PBS) for 30 min, and incu-
bated with an anti-FLAG primary antibody for 2 h at RT.
The cells were then washed 3 times (10 min each) in PBS
and incubated with a secondary antibody for 1 h at 37°C.
Rhodamine-conjugated goat anti-mouse immunoglobu-
lin G (IgG; ZhongShan Biotechnology) was used as the
secondary antibody.
In vivo ubiquitination
In order to analyze ubiquitination, we transfected the
cells with a myc-tagged RNF122 vector and hemaggluti-
nin (HA)-tagged ubiquitin, as described previously. Next,
we harvested the cells and incubated them with 1 volume
of 2% SDS in TBS (10 mM Tris-HCl, pH 8.0) at 95°C for
10 min in order to achieve lysis. Subsequently, we added 9
volumes of 1% Triton X-100 and 2 mM EDTA in TBS to
the cell lysates, and incubated the lysates on ice for 1 h.
The protein concentrations of the lysates were deter-
mined by the bicinchoninic acid (BCA) assay. For immu-
noprecipitation, 1 mg of protein was incubated with the
anti-myc antibody at 4°C overnight; subsequently, this
mixture was incubated with protein G beads for 2 h. The
beads were washed twice with NaCl (1 M) in TBS supple-
mented with NP-40 (1%), β-mercaptoethanol (0.05%),
and EDTA (1 mM). The proteins were loaded onto a 12%
SDS-PAGE gel and analyzed by immunoblotting using
the aforementioned antibodies and an ECL detection kit
(GE Healthcare, USA).
In vitro ubiquitination
In vitro ubiquitination was performed according to the
instructions provided with the ubiquitination kit
( B i o M o l ,  U S A ) .  B r i e f l y ,  t h e  a s s a y s  w e r e  c a r r i e d  o u t  a t
30°C in a 50-μL reaction mixture containing 25 mM 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES),
100 U/mL of isopentenylpyrophosphate (IPP) (Sigma-
Aldrich, St Louis, MO), 50 mM DTT, 50 mM EDTA, 1
mM Mg-ATP (pH 7.5), 100 nM E1 enzyme, 1 μM E2
enzyme, 10 μM GST-RNF122-ΔTM (or mutant GST-
RNF122-ΔTM) fusion protein, and 2.5 μM biotin-labeled
ubiquitin. After 30-60 min, the reactions were terminated
by the addition of a non-reducing gel loading buffer, and
subsequently the protein components were separated by
SDS-PAGE and analyzed by western blotting using the
HRP-streptavidin antibody.
Yeast Two-Hybrid Screening
Yeast Two-Hybrid Screening was performed at Shanghai
Genomics (Shanghai, China). The two-hybrid screening
system has been previously described [22]. Briefly, the
library consisted of 1500 known genes associated with
cell apoptosis, cell proliferation, and cell cycles. Each
ORF was amplified by PCR using Pfu DNA polymerase
and cloned into pGBK-RC, a Gal4 DNA-binding domain-
based bait vector, and pGAD-RC, a Gal4 activation
domain-based prey vector, following the MATCH-
MAKER GAL4 Two-Hybrid System 3 and Libraries User
Manual PT3247-1 (PR94575) protocol (Clontech, Moun-
tain View , CA). Plasmids with inserts of expected sizes
were confirmed by colony PCR followed by agarose gel
electrophoresis. RNF122 bait vector and prey vectors
were cotransfected in yeast Y190 and spread into SD/-T-
L-H. Formed colonies were picked out, cracked in lique-
facient nitrogen, and subsequently utilized in colony lift
filter assays.
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